Neuropace Stock Price on November 28, 2023
| NPCE Stock | USD 11.97 0.06 0.50% |
If you're considering investing in Neuropace Stock, it is important to understand the factors that can impact its price. As of today, the current price of Neuropace stands at 11.97, as last reported on the 19th of January, with the highest price reaching 12.09 and the lowest price hitting 11.75 during the day. Neuropace is somewhat reliable given 3 months investment horizon. Neuropace has Sharpe Ratio of 0.22, which conveys that the firm had a 0.22% return per unit of risk over the last 3 months. We were able to break down thirty different technical indicators, which can help you to evaluate if expected returns of 1.2% are justified by taking the suggested risk. Use Neuropace Downside Deviation of 3.68, risk adjusted performance of 0.1771, and Mean Deviation of 3.55 to evaluate company specific risk that cannot be diversified away.
The current year's Total Stockholder Equity is expected to grow to about 24.9 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 27 M. . At present, Neuropace's Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.24, whereas Price To Operating Cash Flows Ratio is forecasted to decline to (12.78). Neuropace Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Neuropace |
Sharpe Ratio = 0.222
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NPCE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.41 actual daily | 48 52% of assets are more volatile |
Expected Return
| 1.2 actual daily | 23 77% of assets have higher returns |
Risk-Adjusted Return
| 0.22 actual daily | 17 83% of assets perform better |
Based on monthly moving average Neuropace is performing at about 17% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neuropace by adding it to a well-diversified portfolio.
Price Book 36.372 | Enterprise Value Ebitda (16.94) | Price Sales 4.6733 | Shares Float 11.2 M | Wall Street Target Price 16.1667 |
Related Headline
NuVasive Headline on 24th of July 2023
NuVasive Announces Conference Call and Webcast of Second Qua... by finance.yahoo.com
NuVasive, Inc. , the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that it will release its second quarter 2023 results on Wednesday, August 2, 2023, after the close of the market.
Neuropace Valuation on November 28, 2023
It is possible to determine the worth of Neuropace on a given historical date. On November 28, 2023 Neuropace was worth 8.86 at the beginning of the trading date compared to the closed value of 8.75. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Neuropace stock. Still, in general, we apply an absolute valuation method to find Neuropace's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Neuropace where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Neuropace's related companies.
| Open | High | Low | Close | Volume | |
| 8.93 | 9.22 | 8.69 | 8.86 | 45,800 | |
11/28/2023 | 8.86 | 9.04 | 8.57 | 8.75 | 808,400 |
| 8.82 | 8.90 | 8.54 | 8.74 | 223,800 |
| Backtest Neuropace | | | Neuropace History | | | Neuropace Valuation | Previous | Next |
Neuropace Trading Date Momentum on November 28, 2023
| On November 29 2023 Neuropace was traded for 8.74 at the closing time. The top price for the day was 8.90 and the lowest listed price was 8.54 . The trading volume for the day was 223.8 K. The trading history from November 29, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.11% . The trading delta at closing time against the current closing price is 3.89% . |
Neuropace Fundamentals Correlations and Trends
By evaluating Neuropace's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Neuropace's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Neuropace financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Neuropace Stock history
Neuropace investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neuropace is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neuropace will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neuropace stock prices may prove useful in developing a viable investing in Neuropace
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 29.7 M | 27 M | |
| Net Loss | -42.4 M | -44.5 M |
Neuropace Quarterly Net Working Capital |
|
Neuropace Stock Technical Analysis
Neuropace technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Neuropace Period Price Range
Low | January 19, 2025
| High |
0.00 | 0.00 |
Neuropace cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Neuropace January 19, 2025 Market Strength
Market strength indicators help investors to evaluate how Neuropace stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neuropace shares will generate the highest return on investment. By undertsting and applying Neuropace stock market strength indicators, traders can identify Neuropace entry and exit signals to maximize returns
Neuropace Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Neuropace's price direction in advance. Along with the technical and fundamental analysis of Neuropace Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neuropace to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1771 | |||
| Jensen Alpha | 1.04 | |||
| Total Risk Alpha | 0.9324 | |||
| Sortino Ratio | 0.2819 | |||
| Treynor Ratio | 1.41 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Neuropace Stock analysis
When running Neuropace's price analysis, check to measure Neuropace's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuropace is operating at the current time. Most of Neuropace's value examination focuses on studying past and present price action to predict the probability of Neuropace's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuropace's price. Additionally, you may evaluate how the addition of Neuropace to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |